Officials Investigate Potentially Deadly Side Effect of Weight-Loss Drugs

Health officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported pancreas issues. Many cases of pancreatitis are linked to GLP-1, glucagon-like peptide-1 receptor agonists — and many of those cases have been fatal. Nearly 400 reports of pancreatitis are from patients using Mounjaro, Wegovy, Ozempic and liraglutide. A quarter […]

Tirzepatide Outperforms Semaglutide in Head-to-Head Obesity Trial

The glucagon-like peptide 1 receptor agonists semaglutide and tirzepatide have both shown efficacy for obesity management. In clinical trials for the individual drugs, tirzepatide—which is also a glucose-dependent insulinotropic polypeptide receptor agonist—resulted in more weight loss on average than semaglutide did. A new head-to-head trial directly comparing the medications appears to confirm these findings.

[Review] Incretins and the cardiovascular system: bridging digestion with metabolism

The mechanisms driving the cardiovascular and renal benefits of therapies targeting intestinal hormones in type 2 diabetes are still not fully understood. We propose that incretin hormones—glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP)—act as a critical link connecting digestion, metabolism, and cardiovascular function, supporting physiological adaptations to nutrient intake. Incretin hormones help regulate blood […]

Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, continues to shape the future of health and wellness by integrating clinical excellence with a consumer-first digital platform. Offering accessible treatment for chronic and sensitive conditions such as mental health, dermatology, sexual wellness and weight management, the company has delivered over 30 million […]

Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed

By TOM MURPHY, AP Health Writer Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients. And even for people with insurance, coverage remains uneven. “The medications should […]

Ozempic-Like Drug Liraglutide Slashes Migraine Days In Half, Study Finds

A new pilot study suggests that liraglutide, a GLP-1RA prescribed for diabetes and weight management, could help reduce migraine frequency. MementoJpeg/Getty Images An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide might help migraine frequency and severity by reducing intracranial pressure. While promising, it’s too […]